Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?

Detalles Bibliográficos
Autores principales: Babaier, Abdulaziz, Ghatage, Prafull
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477662/
https://www.ncbi.nlm.nih.gov/pubmed/37675330
http://dx.doi.org/10.21037/atm-23-903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477662/
https://www.ncbi.nlm.nih.gov/pubmed/37675330
http://dx.doi.org/10.21037/atm-23-903

Ejemplares similares